Nicholas is a Doctor of Pharmacy candidate 2019, future resident pharmacist, and aspiring biotech analyst. Interests include NDAs, clinical trial critiques, Biotech industry, and Market volatility. My goal is not to bring more purely financial analysis to the forefront, but to instead use my clinical training and limited financial abilities to paint an alternate view on companies, and ultimately, equities I am not a licensed professional in the financial industry, nor do I have a formal education or training in anything but pharmacy. All views are my own and do not represent the views/opinions of any affiliates or employers.